The global rollout of the COVID-19 vaccine has not only taxed the pharmaceutical supply chain but placed it under a magnifying glass, generating concerns about supply chains of non-COVID-related pharmaceutical products. To gain data-driven insights around these questions, FreightWaves’ Zach Strickland interviewed Christopher Engel, the commercial supply chain service director for World Courier, an AmerisourceBergen company.
“The global rollout of the vaccine is estimated to generate about...